Lung Deposition and Clearance of Inhaled Vanadium Pentoxide in Chronically Exposed F344 Rats and B6C3F1 Mice

Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation. Lung weights and lung burdens of vanadium were determined for exposed...

Full description

Saved in:
Bibliographic Details
Published inToxicological sciences Vol. 77; no. 1; pp. 6 - 18
Main Authors Dill, Jeffrey A., Lee, Kyeonghee M., Mellinger, Kathleen H., Bates, Derrick J., Burka, Leo T., Roycroft, Joseph H.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.01.2004
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation. Lung weights and lung burdens of vanadium were determined for exposed animals after 1, 5, and 12 days and after 1, 2, 6, 12, and 18 months of V2O5 exposure. Blood vanadium concentrations were determined at 1, 2, 6, 12, and 18 months for all animals including controls. A model that assumed a first-order deposition rate and a first-order elimination rate for vanadium was employed to fit the lung burden data. Comparisons between exposed groups indicated a progressive increase in lung weight with exposure concentration and time on exposure for both species. The vanadium lung burdens appeared to reach steady state in the lowest exposure groups (0.5 and 1 mg/m3 for rats and mice, respectively) but showed a decline in the higher exposure groups. This deposition pattern was similar between rats and mice but the maximum lung burdens were observed at different times (1 or 2 months in mice vs. 6 months in rats). The vanadium deposition rate decreased faster in mice, while the elimination half-lives of vanadium lung burdens were about six- to nine-fold shorter in mice than in rats at 1 and 2 mg/m3. Thus, the retention of vanadium in the lungs at 18 months was lower in mice (~2% retained) compared with rats (13–15% retained) at the common exposure concentrations of 1 and 2 mg/m3. The lung burden data were approximately proportional to the exposure concentration in both species, likely due to concomitant decreases in deposition and elimination to a similar extent with increasing exposure. The area under the lung burden versus time curves and the area under the blood concentration (control-normalized) versus time curves were also proportional to exposure concentration. The progression of pathological changes in the lung with exposure and time is thought to affect the pattern and/or extent of vanadium deposition in the lungs following repeated exposures to V2O5.
AbstractList Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation. Lung weights and lung burdens of vanadium were determined for exposed animals after 1, 5, and 12 days and after 1, 2, 6, 12, and 18 months of V2O5 exposure. Blood vanadium concentrations were determined at 1, 2, 6, 12, and 18 months for all animals including controls. A model that assumed a first-order deposition rate and a first-order elimination rate for vanadium was employed to fit the lung burden data. Comparisons between exposed groups indicated a progressive increase in lung weight with exposure concentration and time on exposure for both species. The vanadium lung burdens appeared to reach steady state in the lowest exposure groups (0.5 and 1 mg/m3 for rats and mice, respectively) but showed a decline in the higher exposure groups. This deposition pattern was similar between rats and mice but the maximum lung burdens were observed at different times (1 or 2 months in mice vs. 6 months in rats). The vanadium deposition rate decreased faster in mice, while the elimination half-lives of vanadium lung burdens were about six- to nine-fold shorter in mice than in rats at 1 and 2 mg/m3. Thus, the retention of vanadium in the lungs at 18 months was lower in mice (approximately 2% retained) compared with rats (13-15% retained) at the common exposure concentrations of 1 and 2 mg/m3. The lung burden data were approximately proportional to the exposure concentration in both species, likely due to concomitant decreases in deposition and elimination to a similar extent with increasing exposure. The area under the lung burden versus time curves and the area under the blood concentration (control-normalized) versus time curves were also proportional to exposure concentration. The progression of pathological changes in the lung with exposure and time is thought to affect the pattern and/or extent of vanadium deposition in the lungs following repeated exposures to V2O5.
Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V sub(2)O sub(5)) at concentrations of 0, 0.5, 1, or 2 mg/m super(3) (rats) and 0, 1, 2, or 4 mg/m super(3) (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation. Lung weights and lung burdens of vanadium were determined for exposed animals after 1, 5, and 12 days and after 1, 2, 6, 12, and 18 months of V sub(2)O sub(5) exposure. Blood vanadium concentrations were determined at 1, 2, 6, 12, and 18 months for all animals including controls. A model that assumed a first-order deposition rate and a first-order elimination rate for vanadium was employed to fit the lung burden data. Comparisons between exposed groups indicated a progressive increase in lung weight with exposure concentration and time on exposure for both species. The vanadium lung burdens appeared to reach steady state in the lowest exposure groups (0.5 and 1 mg/m super(3) for rats and mice, respectively) but showed a decline in the higher exposure groups. This deposition pattern was similar between rats and mice but the maximum lung burdens were observed at different times (1 or 2 months in mice vs. 6 months in rats). The vanadium deposition rate decreased faster in mice, while the elimination half-lives of vanadium lung burdens were about six- to nine-fold shorter in mice than in rats at 1 and 2 mg/m super(3). Thus, the retention of vanadium in the lungs at 18 months was lower in mice (~2% retained) compared with rats (13-15% retained) at the common exposure concentrations of 1 and 2 mg/m super(3). The lung burden data were approximately proportional to the exposure concentration in both species, likely due to concomitant decreases in deposition and elimination to a similar extent with increasing exposure. The area under the lung burden versus time curves and the area under the blood concentration (control-normalized) versus time curves were also proportional to exposure concentration. The progression of pathological changes in the lung with exposure and time is thought to affect the pattern and/or extent of vanadium deposition in the lungs following repeated exposures to V sub(2)O sub(5).
Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for 6 h/day, 5 days/week (for up to 18 months), by whole-body inhalation. Lung weights and lung burdens of vanadium were determined for exposed animals after 1, 5, and 12 days and after 1, 2, 6, 12, and 18 months of V2O5 exposure. Blood vanadium concentrations were determined at 1, 2, 6, 12, and 18 months for all animals including controls. A model that assumed a first-order deposition rate and a first-order elimination rate for vanadium was employed to fit the lung burden data. Comparisons between exposed groups indicated a progressive increase in lung weight with exposure concentration and time on exposure for both species. The vanadium lung burdens appeared to reach steady state in the lowest exposure groups (0.5 and 1 mg/m3 for rats and mice, respectively) but showed a decline in the higher exposure groups. This deposition pattern was similar between rats and mice but the maximum lung burdens were observed at different times (1 or 2 months in mice vs. 6 months in rats). The vanadium deposition rate decreased faster in mice, while the elimination half-lives of vanadium lung burdens were about six- to nine-fold shorter in mice than in rats at 1 and 2 mg/m3. Thus, the retention of vanadium in the lungs at 18 months was lower in mice (~2% retained) compared with rats (13–15% retained) at the common exposure concentrations of 1 and 2 mg/m3. The lung burden data were approximately proportional to the exposure concentration in both species, likely due to concomitant decreases in deposition and elimination to a similar extent with increasing exposure. The area under the lung burden versus time curves and the area under the blood concentration (control-normalized) versus time curves were also proportional to exposure concentration. The progression of pathological changes in the lung with exposure and time is thought to affect the pattern and/or extent of vanadium deposition in the lungs following repeated exposures to V2O5.
Author Burka, Leo T.
Roycroft, Joseph H.
Dill, Jeffrey A.
Bates, Derrick J.
Lee, Kyeonghee M.
Mellinger, Kathleen H.
Author_xml – sequence: 1
  givenname: Jeffrey A.
  surname: Dill
  fullname: Dill, Jeffrey A.
  organization: Battelle, Toxicology Northwest, Richland, Washington 99352, and
– sequence: 2
  givenname: Kyeonghee M.
  surname: Lee
  fullname: Lee, Kyeonghee M.
  organization: Battelle, Toxicology Northwest, Richland, Washington 99352, and
– sequence: 3
  givenname: Kathleen H.
  surname: Mellinger
  fullname: Mellinger, Kathleen H.
  organization: Battelle, Toxicology Northwest, Richland, Washington 99352, and
– sequence: 4
  givenname: Derrick J.
  surname: Bates
  fullname: Bates, Derrick J.
  organization: Battelle, Toxicology Northwest, Richland, Washington 99352, and
– sequence: 5
  givenname: Leo T.
  surname: Burka
  fullname: Burka, Leo T.
  organization: National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
– sequence: 6
  givenname: Joseph H.
  surname: Roycroft
  fullname: Roycroft, Joseph H.
  organization: National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
BackLink https://www.ncbi.nlm.nih.gov/pubmed/14600283$$D View this record in MEDLINE/PubMed
BookMark eNpFkE1P3DAQQK0KVL565Fr51FtgbMfO5giBLaCFVkBbxMVy7EnXJWtv40Ra_j2BXcHJI8_TG-ntka0QAxJyyOCIQSmO-7hK1h8_NXMA-Ynsjp8qg5KXW5tZwQR2yF5K_wAYU1B-JjssVwB8InZJOxvCX3qGy5h872OgJjhatWg6EyzS2NDLMDctOvrbBOP8sKA_MYxHvUPqA63mXQzemrZ9puer0TKSU5Hn9Nb06U12qioxZfTaWzwg241pE37ZvPvk1_T8vrrIZj--X1Yns8zmSvSZlTVroMmlkNIqVziwZe1EqYwEN6lrKbliKMTEWiuKRtUFMGNry5GDKw0X--Tb2rvs4v8BU68XPllsWxMwDkmzkvOC81cwW4O2iyl12Ohl5xeme9YM9Gtevc6r13lH_utGPNQLdB_0pueH0KceV-970z1pVYhC6ouHR_3nhhePOb_TV-IFasiIMA
CitedBy_id crossref_primary_10_1186_1465_9921_8_34
crossref_primary_10_1191_0748233705th232oa
crossref_primary_10_1002_sim_2654
crossref_primary_10_1002_jat_1695
crossref_primary_10_1002_jat_2873
crossref_primary_10_1007_s12011_024_04101_y
crossref_primary_10_1080_10937400903094166
crossref_primary_10_1007_s00216_009_3277_8
crossref_primary_10_1080_15476910601119350
crossref_primary_10_1016_j_yrtph_2020_104650
crossref_primary_10_1016_j_yrtph_2014_04_013
crossref_primary_10_1016_j_impact_2020_100214
crossref_primary_10_3109_08958378_2014_935535
crossref_primary_10_3390_ijerph18168457
crossref_primary_10_1293_tox_24_149
crossref_primary_10_1007_s12011_018_1540_6
crossref_primary_10_1007_s11164_014_1573_1
ContentType Journal Article
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
C1K
DOI 10.1093/toxsci/kfh005
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE
Toxicology Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1096-0929
EndPage 18
ExternalDocumentID 10_1093_toxsci_kfh005
14600283
ark_67375_HXZ_WN27Z42S_J
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
-E4
.2P
.I3
.ZR
0R~
123
18M
1B1
1TH
1~5
29Q
2WC
4.4
48X
4G.
53G
5RE
5VS
5WA
5WD
7-5
70D
A8Z
AABZA
AACTN
AACZT
AAEDT
AAHBH
AAIMJ
AAJKP
AAJQQ
AALRI
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AAQXK
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
AAXUO
ABEJV
ABEUO
ABIXL
ABJNI
ABKDP
ABMAC
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQTQ
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACMRT
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADMUD
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AHXPO
AIJHB
AJEEA
AKHUL
AKRWK
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APWMN
AQDSO
ARIXL
ASPBG
ATGXG
ATTQO
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSCLL
BSWAC
BTRTY
BVRKM
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DM4
DU5
D~K
E3Z
EBD
EBS
EDH
EE~
EJD
ELUNK
EMOBN
ESTFP
F5P
F9B
FDB
FEDTE
FGOYB
FHSFR
FIRID
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HH5
HVGLF
HW0
HZ~
I-F
IHE
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
LG5
M-Z
M49
N9A
NGC
NLBLG
NOMLY
NOYVH
NQ-
NTWIH
NU-
NVLIB
O-L
O0~
O9-
OAWHX
OBOKY
OCZFY
ODMLO
OHT
OJQWA
OJZSN
OK1
OPAEJ
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
Q1.
Q5Y
R2-
R44
RD5
RIG
RNI
ROL
ROX
RPZ
RUSNO
RW1
RXO
RZO
SSZ
SV3
TJX
TLC
TR2
UHS
W8F
WOQ
X7H
XPP
YAYTL
YCJ
YKOAZ
YXANX
ZGI
ZKX
ZMT
ZXP
~02
~91
CGR
CUY
CVF
ECM
EIF
NPM
AASNB
AAYXX
CITATION
7U7
C1K
ID FETCH-LOGICAL-c463t-c5b1f0f45355c6d7d0c9bd396a50d8bb55261e338ccc37f6b701acbc2e20d9a23
ISSN 1096-6080
1096-0929
IngestDate Fri Oct 25 22:23:01 EDT 2024
Fri Aug 23 02:09:41 EDT 2024
Tue Oct 15 23:31:05 EDT 2024
Wed Oct 30 09:38:42 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c463t-c5b1f0f45355c6d7d0c9bd396a50d8bb55261e338ccc37f6b701acbc2e20d9a23
Notes ark:/67375/HXZ-WN27Z42S-J
istex:C9149C8F14C92F9D34CC4ED69A8D925F0D1E0174
PII:1096-0929
local:0770006
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://academic.oup.com/toxsci/article-pdf/77/1/6/10892428/z1200104000006.pdf
PMID 14600283
PQID 19227222
PQPubID 23462
PageCount 13
ParticipantIDs proquest_miscellaneous_19227222
crossref_primary_10_1093_toxsci_kfh005
pubmed_primary_14600283
istex_primary_ark_67375_HXZ_WN27Z42S_J
PublicationCentury 2000
PublicationDate 2004-01-01
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – month: 01
  year: 2004
  text: 2004-01-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Toxicological sciences
PublicationTitleAlternate Toxicol. Sci
PublicationYear 2004
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0011609
Score 1.9129868
Snippet Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V2O5) at concentrations of 0, 0.5, 1, or 2 mg/m3 (rats) and 0, 1, 2, or 4 mg/m3 (mice) for...
Female F344 rats and B6C3F1 mice were exposed to vanadium pentoxide (V sub(2)O sub(5)) at concentrations of 0, 0.5, 1, or 2 mg/m super(3) (rats) and 0, 1, 2,...
SourceID proquest
crossref
pubmed
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 6
SubjectTerms Administration, Inhalation
Animals
chronic inhalation
clearance
Dose-Response Relationship, Drug
Female
Lung - drug effects
Lung - metabolism
Lung - pathology
lung deposition
Mice
Mice, Inbred Strains
Models, Biological
Organ Size - drug effects
Rats
Rats, Inbred F344
Toxicity Tests, Chronic
toxicokinetics
vanadium
Vanadium Compounds - administration & dosage
Vanadium Compounds - pharmacokinetics
Vanadium Compounds - toxicity
vanadium pentoxide
vanadium pentoxide (V2O5)
Title Lung Deposition and Clearance of Inhaled Vanadium Pentoxide in Chronically Exposed F344 Rats and B6C3F1 Mice
URI https://api.istex.fr/ark:/67375/HXZ-WN27Z42S-J/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/14600283
https://search.proquest.com/docview/19227222
Volume 77
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Zb9MwGLdglRASQlBglNMPqC9bWA7baR5HtapaD6aRsmovUXxEm1alaO2klb-ez0eSToA4XqIocu0038_f4e9C6EPuSxGrQHm8R5VHAsG9BDQDL9HCn-S9UJrC85MpG87I8ZzOm3ZHJrtkzT-K77_MK_kfqsIzoKvOkv0HytaTwgO4B_rCFSgM17-i8Rh2KnCMKvDKOAL6ug-EyQMwSSIXIADk3lcT2qVj3kHGLG8vpSkV4grj5ovFRpc8Xq5g5CAiZO80X9vSzZ9YPxoEOrb-TsRQClOImms6Idp0qHcVshtwuGifUXP0OlGmFriL6KjdVfo81er1zl1VnUeQrfMIy0LBKPKYb_szVTzWtWrZxpJlmGxL8lpG_BNPt_Wu4OPA34Gbq-LC92kjviqX_fRzNpiNx1l6NE_vo1YIjAc4XutwdHo2qv1KATNBP_U7uqqrsMSBXeDATn9HS2npDXf7exPEqCLpE_TY2RD40ALiKbqnyjZ6MHFREm3UPbH1yDf7OG3S61b7uItPmkrlmzZ6ZA9tsc1Fe4YWGlC4ARQGDOAaUHhZYAcoXAEK14DClyXeAhR2gMIaUFgDykxmAYU1oJ6j2eAo7Q89147DE4RFa09QHhR-QSioqILJWPoi4TJKWE592eOcUrDGVRT1hBBRXDAe-0EuuAhV6MskD6MXaKdcluolwhHjAS2UAuVakkKEia8Kpa1XRakMC95B3erzZ99s1ZXMRktEmaVTZukEAw1x6lH59ZUOVYxpNpyfZ2fTMD4n4ZfsuIPeV9TLgIFqr1hequXNKgMTJ4xBS-6gXUvUZkXCTCuvV3_87Wv0sNkKb9DO-vpGvQVldc3fOQT-AA2Flm4
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+Deposition+and+Clearance+of+Inhaled+Vanadium+Pentoxide+in+Chronically+Exposed+F344+Rats+and+B6C3F1+Mice&rft.jtitle=Toxicological+sciences&rft.au=Dill%2C+JA&rft.au=Lee%2C+K+M&rft.au=Mellinger%2C+KH&rft.au=Bates%2C+D+J&rft.date=2004-01-01&rft.issn=1096-6080&rft.volume=77&rft.issue=1&rft.spage=6&rft.epage=18&rft_id=info:doi/10.1093%2Ftoxsci%2Fkfh005&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6080&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6080&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6080&client=summon